The following was written about RFE in the latest Euroz update. RFE's production is approx 1000-1300 BOEPD. I think the same logic applies to AOK. Perhaps event more so given the consistency of results, close proximity of wells, and upcoming reserve report.
"As a consequence, we expect strong growth in production come February and March.
With continued execution operationally, strong reserves growth will improve RFEs access to low cost debt.
We expect that the Company will have debt funding in-place in the short-term. This will be sized appropriately with increasing availability with on-going development.
Given current costs of capital in the US, any facility will be very low cost."
- Forums
- ASX - By Stock
- debt funding
The following was written about RFE in the latest Euroz update....
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AOK (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.833M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $49 | 16.35K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 20333665 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 11137932 | 7 |
Last trade - 11.51am 18/11/2024 (20 minute delay) ? |
Featured News
AOK (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online